Aptamer-guided nanomedicines for anticancer drug delivery

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA Polymerase

Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,421 · see citing works

Prospective identification of tumorigenic breast cancer cells

Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,388 · see citing works

In vitro selection of RNA molecules that bind specific ligands

Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,845 · see citing works

Nanocarriers as an emerging platform for cancer therapy

Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710 · see citing works

Drug Delivery Systems: Entering the Mainstream

Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552 · see citing works

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,865 · see citing works

Selection of single-stranded DNA molecules that bind and inhibit human thrombin

Bock, L. C., Griffin, L. C., Latham, J. A., Vermaas, E. H., & Toole, J. J. (1992) · Nature · doi:10.1038/355564a0 · Cited by 2,460 · see citing works

Evolution of the Cancer Stem Cell Model

Kreso, A., & Dick, J. E. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.006 · Cited by 2,212 · see citing works

Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics

Jayasena, S. D. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.9.1628 · Cited by 2,146 · see citing works

The cancer stem cell: premises, promises and challenges

Clevers, H. (2011) · Nature Medicine · doi:10.1038/nm.2304 · Cited by 1,915 · see citing works

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,667 · see citing works

Nanocarriers’ entry into the cell: relevance to drug delivery

Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,549 · see citing works

Aptamers evolved from live cells as effective molecular probes for cancer study

Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P. R., Sefah, K., Yang, C. J., & Tan, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602615103 · Cited by 1,519 · see citing works

Mediating Tumor Targeting Efficiency of Nanoparticles Through Design

Perrault, S. D., Walkey, C., Jennings, T. L., Fischer, H. C., & Chan, W. C. W. (2009) · Nano Letters · doi:10.1021/nl900031y · Cited by 1,516 · see citing works

Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology

Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W. C., Farokhzad, O. C., Barry, S. T., Gabizón, A., Grodzinski, P. A., & Blakey, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4561 · Cited by 1,493 · see citing works

SELEX—A (r)evolutionary method to generate high-affinity nucleic acid ligands

Stoltenburg, R., Reinemann, C., & Strehlitz, B. (2007) · Biomolecular Engineering · doi:10.1016/j.bioeng.2007.06.001 · Cited by 1,432 · see citing works

Dendrimers: synthesis, applications, and properties

Abbasi, E., Aval, S. F., Akbarzadeh, A., Milani, M., Nasrabadi, H. T., Joo, S. W., Hanifehpour, Y., Nejati‐Koshki, K., & Pashaei‐Asl, R. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-247 · Cited by 1,283 · see citing works

Formulation of functionalized PLGA-PEG Nanoparticles for in vivo targeted drug delivery

Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.047 · Cited by 1,273 · see citing works

In Vitro Selection of Functional Nucleic Acids

Wilson, D. S., & Szostak, J. W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.611 · Cited by 1,209 · see citing works

Cellular Uptake, Intracellular Trafficking, and Cytotoxicity of Nanomaterials

Zhao, F., Zhao, Y., Liu, Y., Chang, X., Chen, C., & Zhao, Y. (2011) · Small · doi:10.1002/smll.201100001 · Cited by 1,179 · see citing works

Introduction to metallic nanoparticles

Mody, V. V., Siwale, R. C., Singh, A. V., & Mody, H. (2010) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.72127 · Cited by 1,045 · see citing works

Quantum Dot−Aptamer Conjugates for Synchronous Cancer Imaging, Therapy, and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy Transfer

Bagalkot, V., Zhang, L., Levy‐Nissenbaum, E., Jon, S., Kantoff, P. W., Langer, R., & Farokhzad, O. C. (2007) · Nano Letters · doi:10.1021/nl071546n · Cited by 1,036 · see citing works

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles

Dhar, S., Gu, F., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994 · see citing works

Aptamers: An Emerging Class of Therapeutics

Nimjee, S. M., Rusconi, C. P., & Sullenger, B. A. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.062904.144915 · Cited by 940 · see citing works

Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer

Ghosh, A., & Heston, W. D. W. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10661 · Cited by 883 · see citing works

Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures

Ellington, A. D., & Szostak, J. W. (1992) · Nature · doi:10.1038/355850a0 · Cited by 858 · see citing works

Enhanced Permeability and Retention (EPR) Effect for Anticancer Nanomedicine Drug Targeting

Greish, K. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-609-2_3 · Cited by 841 · see citing works

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers

Gu, F., Zhang, L., Teply, B. A., Mann, N., Wang, A. Z., Radovic‐Moreno, A. F., Langer, R., & Farokhzad, O. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711714105 · Cited by 714 · see citing works

Current approaches in SELEX: An update to aptamer selection technology

Darmostuk, M., Rimpelová, S., Gbelcová, H., & Ruml, T. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.02.008 · Cited by 703 · see citing works

Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery

Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., Jiang, X., Yao, L., Chen, J., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.004 · Cited by 567 · see citing works

Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.

Lupold, S. E., Hicke, B. J., Lin, Y. H., & Coffey, D. S. (2002) · PubMed · Cited by 564 · see citing works

Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents

Rohloff, J. C., Gelinas, A. D., Jarvis, T. C., Ochsner, U. A., Schneider, D. J., Gold, L., & Janjic, N. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.49 · Cited by 533 · see citing works

Dendrimers: properties and applications.

Klajnert‐Maculewicz, B., & Bryszewska, M. J. (2001) · Acta Biochimica Polonica · doi:10.18388/abp.2001_5127 · Cited by 526 · see citing works

Selection of DNA Aptamers against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture

Song, Y., Zhu, Z., An, Y., Zhang, W., Zhang, H., Liu, D., Yu, C., Duan, W., & Yang, C. J. (2013) · Analytical Chemistry · doi:10.1021/ac400366b · Cited by 525 · see citing works

Cell-Specific Aptamer Probes for Membrane Protein Elucidation in Cancer Cells

Shangguan, D., Cao, Z. C., Meng, L. H., Mallikaratchy, P. R., Sefah, K., Wang, H., Li, Y., & Tan, W. (2008) · Journal of Proteome Research · doi:10.1021/pr700894d · Cited by 465 · see citing works

Polymeric nanoparticles for targeted treatment in oncology: current insights

Joshi, M. D., Patravale, V. B., & Prabhu, R. H. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s56932 · Cited by 447 · see citing works

Protein-RNA interactions: a structural analysis

Jones, S. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.4.943 · Cited by 440 · see citing works

Protein-DNA interactions: a structural analysis

Jones, S., van Heyningen, P., Berman, H. M., & Thornton, J. M. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2659 · Cited by 424 · see citing works

Near‐Infrared Light‐Triggered, Targeted Drug Delivery to Cancer Cells by Aptamer Gated Nanovehicles

Yang, X., Liu, X., Liu, Z., Pu, F., Ren, J., & Qu, X. (2012) · Advanced Materials · doi:10.1002/adma.201104797 · Cited by 424 · see citing works

2011: the immune hallmarks of cancer

Cavallo, F., Giovanni, C. D., Nanni, P., Forni, G., & Lollini, P. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0968-0 · Cited by 417 · see citing works

DNA Aptamers That Bind to MUC1 Tumour Marker: Design and Characterization of MUC1-Binding Single-Stranded DNA Aptamers

Ferreira, C. S. M., Matthews, C. S., & Missailidis, S. (2006) · Tumor Biology · doi:10.1159/000096085 · Cited by 411 · see citing works

Discovering DNA: Friedrich Miescher and the early years of nucleic acid research

Dahm, R. (2007) · Human Genetics · doi:10.1007/s00439-007-0433-0 · Cited by 391 · see citing works

Reversible Cell‐Specific Drug Delivery with Aptamer‐Functionalized Liposomes

Cao, Z. C., Tong, R., Mishra, A., Xu, W., Wong, G. C. L., Cheng, J., & Lu, Y. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901452 · Cited by 372 · see citing works

Nanotechnology and Cancer

Heath, J. R., & Davis, M. E. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.59.061506.185523 · Cited by 360 · see citing works

Assembly of Aptamer Switch Probes and Photosensitizer on Gold Nanorods for Targeted Photothermal and Photodynamic Cancer Therapy

Wang, J., Zhu, G., You, M., Song, E., Shukoor, M. I., Zhang, K., Altman, M. O., Chen, Y., Zhu, Z., Huang, C. Z., et al. (2012) · ACS Nano · doi:10.1021/nn300694v · Cited by 358 · see citing works

Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications

Rizzo, L. Y., Theek, B., Storm, G., Kiessling, F. M., & Lammers, T. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.02.020 · Cited by 340 · see citing works

DNA aptamer–micelle as an efficient detection/delivery vehicle toward cancer cells

Wu, Y., Sefah, K., Liu, H., Wang, R., & Tan, W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909611107 · Cited by 330 · see citing works

Aptamer-Conjugated DNA Icosahedral Nanoparticles As a Carrier of Doxorubicin for Cancer Therapy

Chang, M., Yang, C., & Huang, D. (2011) · ACS Nano · doi:10.1021/nn200693a · Cited by 318 · see citing works

Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer

Savla, R., Taratula, O., Garbuzenko, O. B., & Minko, T. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.015 · Cited by 314 · see citing works

Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas

Li, L., Hou, J., Liu, X., Guo, Y., Wu, Y., Zhang, L., & Yang, Z. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.019 · Cited by 286 · see citing works

Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology

Shu, D., Li, H., Shu, Y., Xiong, G., Carson, W. E., Haque, F., Xu, R., & Guo, P. (2015) · ACS Nano · doi:10.1021/acsnano.5b02471 · Cited by 270 · see citing works

RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule

Shigdar, S. L., Lin, J., Yu, Y., Pastuovic, M., Wei, M. Q., & Duan, W. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01897.x · Cited by 240 · see citing works

Photothermal Therapeutic Response of Cancer Cells to Aptamer–Gold Nanoparticle-Hybridized Graphene Oxide under NIR Illumination

Yang, L., Tseng, Y., Suo, G., Chen, L., Yu, J., Chiu, W.-J., Huang, C., & Lin, C. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/am508117e · Cited by 240 · see citing works

Selective Photothermal Therapy for Mixed Cancer Cells Using Aptamer-Conjugated Nanorods

Huang, Y., Sefah, K., Bamrungsap, S., Chang, H., & Tan, W. (2008) · Langmuir · doi:10.1021/la801969c · Cited by 234 · see citing works

Release of Photoactivatable Drugs from Plasmonic Nanoparticles for Targeted Cancer Therapy

Luo, Y.-L., Shiao, Y.-S., & Huang, Y. (2011) · ACS Nano · doi:10.1021/nn201592s · Cited by 234 · see citing works

Multifunctional Plasmonic Shell–Magnetic Core Nanoparticles for Targeted Diagnostics, Isolation, and Photothermal Destruction of Tumor Cells

Fan, Z., Shelton, M. P., Singh, A. K., Senapati, D., Khan, S. A., & Ray, P. C. (2012) · ACS Nano · doi:10.1021/nn2045246 · Cited by 228 · see citing works

Image‐Guided Prostate Cancer Therapy Using Aptamer‐Functionalized Thermally Cross‐Linked Superparamagnetic Iron Oxide Nanoparticles

Yu, M. K., Kim, D., Lee, I., So, J., Jeong, Y. Y., & Jon, S. (2011) · Small · doi:10.1002/smll.201100472 · Cited by 225 · see citing works

Viral Capsid DNA Aptamer Conjugates as Multivalent Cell-Targeting Vehicles

Tong, G. J., Hsiao, S. C., Carrico, Z. M., & Francis, M. B. (2009) · Journal of the American Chemical Society · doi:10.1021/ja903857f · Cited by 224 · see citing works

Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer

Xu, W., Siddiqui, I. A., Nihal, M., Pilla, S., Rosenthal, K. A., Mukhtar, H., & Gong, S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.006 · Cited by 223 · see citing works

Dual-Surface Modified Virus Capsids for Targeted Delivery of Photodynamic Agents to Cancer Cells

Stephanopoulos, N., Tong, G. J., Hsiao, S. C., & Francis, M. B. (2010) · ACS Nano · doi:10.1021/nn1014769 · Cited by 212 · see citing works

Aptamer-Mediated Up-conversion Core/MOF Shell Nanocomposites for Targeted Drug Delivery and Cell Imaging

Deng, K., Hou, Z., Li, X., Li, C., Zhang, Y., Deng, X., Cheng, Z., & Lin, J. (2015) · Scientific Reports · doi:10.1038/srep07851 · Cited by 206 · see citing works

Polydopamine-Based Surface Modification of Novel Nanoparticle-Aptamer Bioconjugates for In Vivo Breast Cancer Targeting and Enhanced Therapeutic Effects

Tao, W., Zeng, X., Wu, J., Zhu, X., Yu, X., Zhang, X., Zhang, J., Liu, G., & Mei, L. (2016) · Theranostics · doi:10.7150/thno.14184 · Cited by 204 · see citing works

Nanotechnology platforms and physiological challenges for cancer therapeutics

Kim, K. Y. (2007) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2006.12.002 · Cited by 201 · see citing works

Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells

Alshaer, W., Hillaireau, H., Vergnaud, J., Ismail, S. I., & Fattal, E. (2014) · Bioconjugate Chemistry · doi:10.1021/bc5004313 · Cited by 200 · see citing works

Selective delivery of an anticancer drug with aptamer-functionalized liposomes to breast cancer cells in vitro and in vivo

Xing, H., Tang, L., Yang, X., Hwang, K., Wang, W., Yin, Q., Wong, N. Y., Dobrucki, L. W., Yasui, N., Katzenellenbogen, J. A., et al. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20412j · Cited by 200 · see citing works

Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro

Liu, Z., Duan, J., Song, Y., Ma, J., Wang, F., Lu, X., & Yang, X. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-148 · Cited by 194 · see citing works

AS1411 aptamer tagged PLGA‐lecithin‐PEG nanoparticles for tumor cell targeting and drug delivery

Aravind, A., Jeyamohan, P., Nair, R., Veeranarayanan, S., Nagaoka, Y., Yoshida, Y., Maekawa, T., & Kumar, D. S. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24558 · Cited by 193 · see citing works

Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In Vitro

Yu, C., Hu, Y., Duan, J., Yuan, W., Wang, C., Xu, H., & Yang, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024077 · Cited by 190 · see citing works

Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis

Wang, C., Kang, S., Lee, Y.-H., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.036 · Cited by 186 · see citing works

EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery

Xie, X., Li, F., Zhang, H., Lu, Y., Lian, S., Lin, H., Gao, Y., & Jia, L. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.12.014 · Cited by 186 · see citing works

Liposome-Anchored Vascular Endothelial Growth Factor Aptamers

Willis, M. C., Collins, B., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C., Kellogg, E. A., Gill, S. C., Magallanez, A., Knauer, S., et al. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980002x · Cited by 182 · see citing works

[17] A SELEX primer

Fitzwater, T., & Polisky, B. A. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)67019-0 · Cited by 174 · see citing works

A Controllable Aptamer-Based Self-Assembled DNA Dendrimer for High Affinity Targeting, Bioimaging and Drug Delivery

Zhang, H., Ma, Y., Xie, Y., An, Y., Huang, Y., Zhu, Z., & Yang, C. J. (2015) · Scientific Reports · doi:10.1038/srep10099 · Cited by 174 · see citing works

RNA aptamers targeting cancer stem cell marker CD133

Shigdar, S. L., Qiao, L., Zhou, S., Xiang, D., Wang, T., Li, Y., Lim, L. Y., Kong, L., Li, L., & Duan, W. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.032 · Cited by 174 · see citing works

Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells

Xiang, D., Shigdar, S. L., Yang, W. R., Duan, W., Li, Q., Lin, J., Liu, K., & Li, L. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s59779 · Cited by 169 · see citing works

A liposome-based nanostructure for aptamer directed delivery

Kang, H., O’Donoghue, M. B., Liu, H., & Tan, W. (2009) · Chemical Communications · doi:10.1039/b916911c · Cited by 168 · see citing works

Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer

Azhdarzadeh, M., Atyabi, F., Saei, A. A., Varnamkhasti, B. S., Omidi, Y., Fateh, M., Ghavami, M., Shanehsazzadeh, S., & Dinarvand, R. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.02.058 · Cited by 163 · see citing works

Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo

Alibolandi, M., Taghdisi, S. M., Ramezani, P., Shamili, F. H., Farzad, S. A., Abnous, K., & Ramezani, M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.044 · Cited by 163 · see citing works

Reversible Targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes

Taghdisi, S. M., Lavaee, P., Ramezani, M., & Abnous, K. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.005 · Cited by 157 · see citing works

Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In Vitro

Hu, Y., Duan, J., Zhan, Q., Wang, F., Lu, X., & Yang, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031970 · Cited by 149 · see citing works

RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo

Baek, S. E., Lee, K. H., Park, Y. S., Oh, D., Oh, S., Kim, K., & Kim, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.018 · Cited by 148 · see citing works

Liposome-Anchored Vascular Endothelial Growth Factor Aptamers

Willis, M. C., Collins, B. T., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C. J., Kellogg, E. A., Gill, S. C., Magallanez, A., Knauer, S., et al. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980200o · Cited by 146 · see citing works

Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery

Taghavi, S., Ramezani, M., Alibolandi, M., Abnous, K., & Taghdisi, S. M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.008 · Cited by 145 · see citing works

A polyvalent aptamer system for targeted drug delivery

Zhang, Z., Ali, M. M., Eckert, M. A., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.079 · Cited by 142 · see citing works

Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model

Alshaer, W., Hillaireau, H., Vergnaud, J., Mura, S., Deloménie, C., Sauvage, F., Ismail, S. I., & Fattal, E. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.022 · Cited by 140 · see citing works

Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo

Taghdisi, S. M., Danesh, N. M., Ramezani, M., Lavaee, P., Jalalian, S. H., Robati, R. Y., & Abnous, K. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.03.013 · Cited by 139 · see citing works

An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance

Liao, Z., Chuang, E., Lin, C.-C., Ho, Y., Lin, K., Cheng, P., Chen, K., Wei, H.-J., & Sung, H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.032 · Cited by 137 · see citing works

Targeted delivery of anticancer drugs by aptamer AS1411 mediated Pluronic F127/cyclodextrin-linked polymer composite micelles

Li, X., Yang, Y. L., Ji, Q., & Qiu, L. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.08.013 · Cited by 136 · see citing works

An RNA Alternative to Human Transferrin: A New Tool for Targeting Human Cells

Wilner, S. E., Wengerter, B. C., Maier, K. E., Magalhães, M. D. L. B., del Amo, D. S., Pai, S., Opazo, F., Rizzoli, S. O., Yan, A. C., & Levy, M. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2012.14 · Cited by 135 · see citing works

Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood–Brain Barrier

Monaco, I., Camorani, S., Colecchia, D., Locatelli, E., Calandro, P., Oudin, A., Niclou, S. P., Arra, C., Chiariello, M., Cerchia, L., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00527 · Cited by 134 · see citing works

Epithelial cell adhesion molecule aptamer conjugated PEG–PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro

Alibolandi, M., Ramezani, M., Sadeghi, F., Abnous, K., & Hadizadeh, F. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.035 · Cited by 133 · see citing works

Aptamer-Targeted DNA Nanostructures for Therapeutic Delivery

Charoenphol, P., & Bermudez, H. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500047b · Cited by 132 · see citing works

Targeted chemoimmunotherapy using drug-loaded aptamer–dendrimer bioconjugates

Lee, I., An, S., Yu, M. K., Kwon, H., Im, S., & Jon, S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.025 · Cited by 126 · see citing works

One-Pot Synthesized Aptamer-Functionalized CdTe:Zn2+ Quantum Dots for Tumor-Targeted Fluorescence Imaging in Vitro and in Vivo

Zhang, C., Ji, X., Zhang, Y., et al. (2013) · Analytical Chemistry · doi:10.1021/ac400606e · Cited by 126 · see citing works

Smart Multifunctional Nanostructure for Targeted Cancer Chemotherapy and Magnetic Resonance Imaging

Chen, T., Shukoor, M. I., Wang, R., et al. (2011) · ACS Nano · doi:10.1021/nn202073m · Cited by 125 · see citing works

The formulation of aptamer-coated paclitaxel–polylactide nanoconjugates and their targeting to cancer cells

Tong, R., Yala, L., Fan, T. M., & Cheng, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.009 · Cited by 124 · see citing works

Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells

Yu, Z., Ni, M., Xiong, M., Zhang, X., Cai, G., Chen, H., & Zeng, Q. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s78498 · Cited by 119 · see citing works

Synthetic Aptamer-Polymer Hybrid Constructs for Programmed Drug Delivery into Specific Target Cells

Oh, S. S., Lee, B. F., Leibfarth, F. A., Eisenstein, M. S., Robb, M. J., Lynd, N. A., Hawker, C. J., & Soh, H. T. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5079464 · Cited by 116 · see citing works

Polyvalent Mesoporous Silica Nanoparticle‐Aptamer Bioconjugates Target Breast Cancer Cells

Li, L., Yin, Q., Cheng, J., et al. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200116 · Cited by 114 · see citing works

SELEX: How It Happened and Where It will Go

Gold, L. (2015) · Journal of Molecular Evolution · doi:10.1007/s00239-015-9705-9 · Cited by 114 · see citing works

Ribozymes, the first 20 years

Cech, T. R. (2002) · Biochemical Society Transactions · doi:10.1042/bst0301162 · Cited by 113 · see citing works

Multifunctional nanoparticle–EpCAM aptamer bioconjugates: A paradigm for targeted drug delivery and imaging in cancer therapy

Das, M., Duan, W., & Sahoo, S. K. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.09.002 · Cited by 111 · see citing works

Aptamer-Functionalized Gold Nanoparticles As Photoresponsive Nanoplatform for Co-Drug Delivery

Shiao, Y.-S., Chiu, H.-H., Wu, P.-H., & Huang, Y. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am5026243 · Cited by 109 · see citing works

Specific aptamer-conjugated mesoporous silica–carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy

Wang, K., Yao, H., Meng, Y., et al. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.01.002 · Cited by 104 · see citing works

Combinatorial Selection of DNA Thioaptamers Targeted to the HA Binding Domain of Human CD44

Somasunderam, A., Thiviyanathan, V., Tanaka, T., Li, X., Neerathilingam, M., Lokesh, G. L.-R., Mann, A. P., Peng, Y., Mauro Ferrari, B., Klostergaard, J., et al. (2010) · Biochemistry · doi:10.1021/bi1009503 · Cited by 103 · see citing works

Silver Nanoparticle Gated, Mesoporous Silica Coated Gold Nanorods (AuNR@MS@AgNPs): Low Premature Release and Multifunctional Cancer Theranostic Platform

Zhang, Z., Liu, C., Bai, J., Wu, C. S., Xiao, Y., Li, Y., Zheng, J., Yang, R., & Tan, W. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b00368 · Cited by 103 · see citing works

EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex

Subramanian, N., Kanwar, J. R., Athalya, P. K., Janakiraman, N., Khetan, V., Kanwar, R. K., Eluchuri, S., & Krishnakumar, S. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-014-0108-9 · Cited by 97 · see citing works

Aptamer-targeted delivery of Bcl-xL shRNA using alkyl modified PAMAM dendrimers into lung cancer cells

Ayatollahi, S., Salmasi, Z., Hashemi, M., Askarian, S., Oskuee, R. K., Abnous, K., & Ramezani, M. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.005 · Cited by 96 · see citing works

A nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphoma

Zhao, N., Bagaria, H. G., Wong, M. S., et al. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-2 · Cited by 95 · see citing works

Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer

Powell, D., Chandra, S., Dodson, K., et al. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.01.011 · Cited by 95 · see citing works

MUC-1 aptamer-conjugated dye-doped silica nanoparticles for MCF-7 cells detection

Cai, L., Chen, Z., Chen, M.-Y., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.084 · Cited by 93 · see citing works

Versatile surface engineering of porous nanomaterials with bioinspired polyphenol coatings for targeted and controlled drug delivery

Li, J., Wu, S., Wu, C. S., Qiu, L., Zhu, G., Cui, C., Liu, Y., Hou, W., Wang, Y., Zhang, L., et al. (2016) · Nanoscale · doi:10.1039/c6nr00600k · Cited by 93 · see citing works

A Smart Responsive Dual Aptamers‐Targeted Bubble‐Generating Nanosystem for Cancer Triplex Therapy and Ultrasound Imaging

Zhao, F., Zhou, J., Su, X., Wang, Y., Yan, X., Jia, S., & Du, B. (2017) · Small · doi:10.1002/smll.201603990 · Cited by 93 · see citing works

Thioaptamer Conjugated Liposomes for Tumor Vasculature Targeting

Mann, A. P., Bhavane, R. C., Somasunderam, A., Montalvo-Ortiz, B. L., Ghaghada, K. B., Volk, D. E., Nieves-Alicea, R., Suh, K. S., Mauro Ferrari, B., Annapragada, A., et al. (2010) · Oncotarget · doi:10.18632/oncotarget.261 · Cited by 91 · see citing works

Grafting Aptamers onto Gold Nanostars Increases in Vitro Efficacy in a Wide Range of Cancer Cell Types

Dam, D. H. M., Culver, K. S. B., & Odom, T. W. (2014) · Molecular Pharmaceutics · doi:10.1021/mp4005657 · Cited by 91 · see citing works

Delivering cargoes into cancer cells using DNA aptamers targeting internalized surface portals

Orava, E. W., Cicmil, N., & Gariépy, J. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.02.004 · Cited by 89 · see citing works

Gadolinium Oxide Nanoparticles and Aptamer-Functionalized Silver Nanoclusters-Based Multimodal Molecular Imaging Nanoprobe for Optical/Magnetic Resonance Cancer Cell Imaging

Li, J., You, J., Dai, Y., et al. (2014) · Analytical Chemistry · doi:10.1021/ac503026d · Cited by 89 · see citing works

MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery

Sayari, E., Dinarvand, M., Amini, M., et al. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.05.041 · Cited by 88 · see citing works

Nanoshells for Photothermal Cancer Therapy

Morton, J. G., Day, E. S., Halas, N. J., & West, J. L. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-609-2_7 · Cited by 81 · see citing works

Progress in Aptamer-Mediated Drug Delivery Vehicles for Cancer Targeting and Its Implications in Addressing Chemotherapeutic Challenges

Zhu, J., Huang, H., Dong, S., Ge, L., & Zhang, Y. (2014) · Theranostics · doi:10.7150/thno.9663 · Cited by 81 · see citing works

Double targeting, controlled release and reversible delivery of daunorubicin to cancer cells by polyvalent aptamers-modified gold nanoparticles

Taghdisi, S. M., Danesh, N. M., Lavaee, P., et al. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.01.009 · Cited by 79 · see citing works

Aptamer-Capped Multifunctional Mesoporous Strontium Hydroxyapatite Nanovehicle for Cancer-Cell-Responsive Drug Delivery and Imaging

Li, Z., Liu, Z., Yin, M., Yang, X., Yuan, Q., Ren, J., & Qu, X. (2012) · Biomacromolecules · doi:10.1021/bm301563q · Cited by 79 · see citing works

Targeted and controlled release delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer-modified gold nanoparticles

Danesh, N. M., Lavaee, P., Ramezani, M., et al. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.072 · Cited by 78 · see citing works

Nucleolin targeting AS1411 aptamer modified pH-sensitive micelles for enhanced delivery and antitumor efficacy of paclitaxel

Zhang, J., Chen, R., Fang, X., Chen, F., Wang, Y., & Chen, M. (2015) · Nano Research · doi:10.1007/s12274-014-0619-4 · Cited by 78 · see citing works

In Vitro Selection of Modified RNA Aptamers Against CD44 Cancer Stem Cell Marker

Ababneh, N. A., Alshaer, W., Al‐Louzi, O., Mahafzah, A. M., El-Khateeb, M. S., Hillaireau, H., Noiray, M., Fattal, E., & Ismail, S. I. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0423 · Cited by 76 · see citing works

Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo

Zhao, H., Fan, W., Hao, J., Wu, X., Zeng, G. Q., Zhang, L., Nie, S. F., & Wang, X. D. (2014) · Drug Delivery · doi:10.3109/10717544.2014.920059 · Cited by 76 · see citing works

Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model

Moosavian, S. A., Abnous, K., Badiee, A., & Jaafari, M. R. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.12.009 · Cited by 76 · see citing works

RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery

Pi, F., Zhang, H., Li, H., et al. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.11.015 · Cited by 76 · see citing works

MUC1 aptamer-targeted DNA micelles for dual tumor therapy using doxorubicin and KLA peptide

Charbgoo, F., Alibolandi, M., Taghdisi, S. M., et al. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.12.010 · Cited by 75 · see citing works

An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells

Ara, M. N., Matsuda, T., Hyodo, M., Sakurai, Y., Hatakeyama, H., Ohga, N., Hida, K., & Harashima, H. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.087 · Cited by 74 · see citing works

Aptamer decorated hyaluronan/chitosan nanoparticles for targeted delivery of 5-fluorouracil to MUC1 overexpressing adenocarcinomas

Ghasemi, Z., Dinarvand, R., Mottaghitalab, F., et al. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.12.025 · Cited by 74 · see citing works

A novel aptamer functionalized CuInS2 quantum dots probe for daunorubicin sensing and near infrared imaging of prostate cancer cells

Lin, Z., Ma, Q., Fei, X., et al. (2014) · Analytica Chimica Acta · doi:10.1016/j.aca.2014.01.057 · Cited by 74 · see citing works

A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery

Leach, J., Wang, A., Ye, K., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030380 · Cited by 70 · see citing works

Targeted and ultrasound-triggered drug delivery using liposomes co-modified with cancer cell-targeting aptamers and a thermosensitive polymer

Ninomiya, K., Yamashita, T., Kawabata, S., et al. (2014) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2013.12.023 · Cited by 65 · see citing works

Smart magnetic nanoparticle-aptamer probe for targeted imaging and treatment of hepatocellular carcinoma

Pilapong, C., Sitthichai, S., Thongtem, S., et al. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.07.036 · Cited by 64 · see citing works

Smart bomb AS 1411 aptamer‐functionalized/ PAMAM dendrimer nanocarriers for targeted drug delivery in the treatment of gastric cancer

Behrooz, A. B., Nabavizadeh, F., Adiban, J., et al. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12670 · Cited by 64 · see citing works

In Vivo Cancer Cells Elimination Guided by Aptamer-Functionalized Gold-Coated Magnetic Nanoparticles and Controlled with Low Frequency Alternating Magnetic Field

Belyanina, I. V., Zamay, T. N., Zamay, G. S., et al. (2017) · Theranostics · doi:10.7150/thno.17089 · Cited by 63 · see citing works

Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells

Mosafer, J., Teymouri, M., Abnous, K., Tafaghodi, M., & Ramezani, M. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2016.11.053 · Cited by 60 · see citing works

Tumor-specific hyperthermia with aptamer-tagged superparamagnetic nanoparticles

Pala, K., Serwotka-Suszczak, A. M., Jeleń, F., Jakimowicz, P., & Otlewski, J. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s52539 · Cited by 59 · see citing works

Synthesis and Self-Assembly of Amphiphilic Aptamer-Functionalized Hyperbranched Multiarm Copolymers for Targeted Cancer Imaging

Yu, S., Dong, R., Chen, J., Chen, F., Jiang, W., Zhou, Y., Zhu, X., & Yan, D. (2014) · Biomacromolecules · doi:10.1021/bm5002203 · Cited by 57 · see citing works

Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer

Esfandyari‐Manesh, M., Mohammadi, A., Atyabi, F., Nabavi, S. M., Ebrahimi, S. M., Shahmoradi, E., Varnamkhasti, B. S., Ghahremani, M. H., & Dinarvand, R. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.10.066 · Cited by 56 · see citing works

Targeting cancer cells with controlled release nanocapsules based on a single aptamer

Hernández, F. J., Hernandez, L. I., Pinto, A., et al. (2012) · Chemical Communications · doi:10.1039/c2cc37370j · Cited by 52 · see citing works

Aptamer-Modified Temperature-Sensitive Liposomal Contrast Agent for Magnetic Resonance Imaging

Zhang, K., Liu, M., Tong, X., et al. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00250 · Cited by 51 · see citing works

Aptamer-labeled PLGA nanoparticles for targeting cancer cells

Aravind, A., Varghese, S. H., Veeranarayanan, S., et al. (2012) · Cancer Nanotechnology · doi:10.1007/s12645-011-0024-6 · Cited by 51 · see citing works

Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+ melanoma stem cells

Zeng, Y.-B., Yu, Z., He, Y., et al. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.166 · Cited by 51 · see citing works

Targeted delivery of doxorubicin to breast cancer cells by aptamer functionalized DOTAP/DOPE liposomes

Song, X., Ren, Y., Zhang, J., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4136 · Cited by 49 · see citing works

Aptamer CaCO3 Nanostructures: A Facile, pH‐Responsive, Specific Platform for Targeted Anticancer Theranostics

Zhou, C., Chen, T., Wu, C. S., Zhu, G., Qiu, L., Cui, C., Hou, W., & Tan, W. (2014) · Chemistry - An Asian Journal · doi:10.1002/asia.201403115 · Cited by 48 · see citing works

Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins

Shoyele, S., Maher, C. M., Lakshmikuttyamma, A., et al. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s110488 · Cited by 46 · see citing works

Constructing aptamer anchored nanovesicles for enhanced tumor penetration and cellular uptake of water soluble chemotherapeutics

Li, X., Zhu, X., & Qiu, L. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.02.012 · Cited by 45 · see citing works

Self-assemble gene delivery system for molecular targeting using nucleic acid aptamer

Kurosaki, T., Higuchi, N., Kawakami, S., et al. (2011) · Gene · doi:10.1016/j.gene.2011.09.021 · Cited by 44 · see citing works

DNA Aptamers against Exon v10 of CD44 Inhibit Breast Cancer Cell Migration

Iida, J., Clancy, R., Dorchak, J., Somiari, R. I., Somiari, S., Cutler, M. L., Mural, R., & Shriver, C. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088712 · Cited by 44 · see citing works

Anti-FGFR1 aptamer-tagged superparamagnetic conjugates for anticancer hyperthermia therapy

Jurek, P., Zabłocki, K., Wasko, U. N., Mazurek, M., Otlewski, J., & Jeleń, F. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s125231 · Cited by 44 · see citing works

Development of a Novel DNA Aptamer Ligand Targeting to Primary Cultured Tumor Endothelial Cells by a Cell-Based SELEX Method

Ara, M. N., Hyodo, M., Ohga, N., Hida, K., & Harashima, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050174 · Cited by 43 · see citing works

Epidermal growth factor receptor aptamer‑conjugated polymer‑lipid hybrid nanoparticles enhance salinomycin delivery to osteosarcoma and cancer stem cells

Yu, Z., Chen, F., Qi, X., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5578 · Cited by 42 · see citing works

Tumor cell-specific photothermal killing by SELEX-derived DNA aptamer-targeted gold nanorods

Chandrasekaran, R., Lee, A. S. W., Yap, L. W., et al. (2015) · Nanoscale · doi:10.1039/c5nr07831h · Cited by 39 · see citing works

Two DNA Aptamers against Avian Influenza H9N2 Virus Prevent Viral Infection in Cells

Zhang, Y., Yu, Z., Jiang, F., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123060 · Cited by 35 · see citing works

In vitro study of novel gadolinium-loaded liposomes guided by GBI-10 aptamer for promising tumor targeting and tumor diagnosis by magnetic resonance imaging

Fan, T., Gu, M., Li, K., et al. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s84351 · Cited by 32 · see citing works

Thioaptamer-conjugated CD44-targeted delivery system for the treatment of breast cancer in vitro and in vivo

Fan, W., Wang, X., Ding, B., et al. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1077850 · Cited by 32 · see citing works

Cell Internalization SELEX: In Vitro Selection for Molecules That Internalize into Cells

Yan, A. C., & Levy, M. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-730-3_18 · Cited by 30 · see citing works

A Temperature-Responsive Antibody-Like Nanostructure

Zhou, J. H., Soontornworajit, B., & Wang, Y. (2010) · Biomacromolecules · doi:10.1021/bm100450k · Cited by 25 · see citing works

Identification of RNA Aptamer Specific to Mutant KRAS Protein

Jeong, S., Han, S. R., Lee, Y. J., et al. (2010) · Oligonucleotides · doi:10.1089/oli.2010.0231 · Cited by 23 · see citing works

Nucleic Acid Pool Preparation and Characterization

Piasecki, S. K., Hall, B., & Ellington, A. D. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-557-2_1 · Cited by 20 · see citing works

Enhancement of Thermal Damage to Adenocarcinoma Cells by Iron Nanoparticles Modified with MUC1 Aptamer

Guo, F., Hu, Y. W., Yu, L., et al. (2016) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2016.10941 · Cited by 20 · see citing works

Developing Aptamers by Cell-Based SELEX

Catuogno, S., Esposito, C. L., & de Franciscis, V. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3197-2_3 · Cited by 19 · see citing works

Development of receptor-based inhibitory RNA aptamers for anthrax toxin neutralization

Lee, S.-C., Gedi, V., Ha, N., et al. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.03.043 · Cited by 16 · see citing works

Multifunctional silver nanocluster-hybrid oligonucleotide vehicle for cell imaging and microRNA-targeted gene silencing

Chen, H.-Y., Albert, K., Wen, C.-C., Hsieh, P., Chen, S.-Y., Huang, N.-C., Lo, S., Chen, J., & Hsu, H. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.01.048 · Cited by 15 · see citing works

Microenvironmental Control of MUC1 Aptamer-Guided Acid-Labile Nanoconjugate within Injectable Microporous Hydrogels

Xu, C., Han, X., Jiang, Y., et al. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00324 · Cited by 7 · see citing works

DNA-conjugated gold nanoparticles for ultrasound targeted drug delivery

Kang, S., Luo, Y.-L., Huang, Y., et al. (2012) · IEEE International Ultrasonics Symposium · doi:10.1109/ultsym.2012.0468 · Cited by 4 · see citing works

Liposomes: Structure, composition, types, and clinical applications

Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561 · see citing works

Therapeutic applications of AS1411 aptamer, an update review

Yazdian-Robati, R., Bayat, P., Oroojalian, F., Zargari, M., Ramezani, M., Taghdisi, S. M., & Abnous, K. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.11.118 · Cited by 288 · see citing works

Biotin-decorated all-HPMA polymeric micelles for paclitaxel delivery

Wang, Y., van Steenbergen, M. J., Beztsinna, N., Shi, Y., Lammers, T., van Nostrum, C. F., & Hennink, W. E. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.013 · Cited by 66 · see citing works

Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment

Liang, X., Wang, Y., Shi, H., Dong, M., Han, H., & Li, Q. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s304526 · Cited by 41 · see citing works

Trastuzumab and folic acid functionalized gold nanoclusters as a dual-targeted radiosensitizer for megavoltage radiation therapy of human breast cancer

Samani, R. K., Tavakoli, M. B., Maghsoudinia, F., Motaghi, H., Hejazi, S. H., & Mehrgardi, M. A. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105487 · Cited by 40 · see citing works

Ligand decorated biodegradable nanomedicine in the treatment of cancer

Ahmad, E., Ali, A., Fatima, M. T., Nimisha, Apurva, A., Kumar, A., Sumi, M. P., Sattar, R. S. A., Mahajan, B., & Saluja, S. S. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105544 · Cited by 33 · see citing works

Design and Fabrication of Magnetically Responsive Nanocarriers for Drug Delivery

Kralj, S., Potrč, T., Kocbek, P., Marchesan, S., & Makovec, D. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160813211736 · Cited by 84 · see citing works

Application and Perspective of pH-Responsive Nano Drug Delivery Systems

Goyal, A. K., Rath, G., Faujdar, C., & Malik, B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814029-1.00002-8 · Cited by 26 · see citing works

Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems

Jiang, F., Liu, B., Lu, J. G., Li, F., Li, D., Liang, C., Dang, L., Liu, J., He, B., Shaikh, A. B., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161023784 · Cited by 89 · see citing works

Nanotechnologies for Ocular Surface Disorder Management: A Promising Approach

Diebold, Y., Enríquez‐de‐Salamanca, A., Jarrı́n, M., et al. (2005) · The Ocular Surface · doi:10.1016/s1542-0124(12)70385-3